Abstract
Secukinumab (Cosentyx(R)) is a fully human monoclonal antibody that selectively targets interleukin (IL)-17A, a proinflammatory cytokine involved in t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
